Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.3.1.900
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 48,559,000 $ 57,116,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 21,275,000 18,454,000
Fair Value Write-Up of Acquired Inventory 2,357,000 4,355,000
Deferred income taxes (1,436,000) (1,083,000)
Stock-based compensation expense 4,359,000 3,437,000
Gain on CyVek acquisition 0 (8,300,000)
Other 204,000 (5,000)
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables 5,413,000 1,643,000
Inventories (4,559,000) (4,259,000)
Prepaid expenses (1,510,000) (500,000)
Trade accounts payable and accrued expenses (2,071,000) 957,000
Salaries, wages and related accruals (987,000) 378,000
Income taxes payable (1,232,000) (749,000)
Net cash provided by operating activities 70,372,000 71,444,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions, net of cash acquired (82,888,000) (420,102,000)
Proceeds from maturities of available-for-sale investments 3,930,000 9,880,000
Additions to property and equipment (11,008,000) (8,047,000)
Distributions from unconsolidated entities 0 446,000
Net cash used in investing activities (89,966,000) (417,823,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (23,796,000) (23,335,000)
Proceeds from stock option exercises 1,175,000 7,030,000
Excess tax benefit from stock option exercises 120,000 258,000
Borrowings under line-of-credit agreement 77,000,000 163,000,000
Payments on line-of-credit (26,000,000) (19,000,000)
Net cash provided by (used in) financing activities 28,499,000 127,953,000
Effect of exchange rate changes on cash and cash equivalents (985,000) (7,174,000)
Net increase (decrease) in cash and cash equivalents 7,920,000 (225,600,000)
Cash and cash equivalents at beginning of period 54,532,000 318,568,000
Cash and cash equivalents at end of period $ 62,452,000 $ 92,968,000